Back to Journals » Biologics: Targets and Therapy » Volume 12

Bezlotoxumab: an emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection

Total article views   Abstract views HTML views PDF downloads Totals
12,679 Dovepress* 5,541 1,031+ 1,303 6,572
PubMed Central* 0 6,107 720 6,107
Totals 5,541 7,138 2,023 12,679
*Since 18 January 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
7 0 0 0 3 4

View citations on PubMed Central and Google Scholar